Read More General business news Is Nureca’s stock exit your opportunity to cash out—or a warning sign for the D2C healthcare sector? Nureca plans to delist at ₹285/share. Explore stock performance, investor sentiment, and whether you should buy, sell, or hold ahead of the reverse book building. byPallavi MadhirajuApril 12, 2025